Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 130 articles:
HTML format
Text format



Single Articles


    April 2019
  1. LI L, Kang D, Huang Z, Zhan Z, et al
    Multimodal multiphoton imaging for label-free monitoring of early gastric cancer.
    BMC Cancer. 2019;19:295.
    PubMed     Text format     Abstract available


    March 2019
  2. SUI H, Lou A, Li Z, Yang J, et al
    Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145.
    BMC Cancer. 2019;19:233.
    PubMed     Text format     Abstract available


  3. LIU J, Liu Z, Zhang X, Gong T, et al
    Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
    BMC Cancer. 2019;19:227.
    PubMed     Text format     Abstract available


  4. LU J, Dai Y, Xie JW, Wang JB, et al
    Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution.
    BMC Cancer. 2019;19:216.
    PubMed     Text format     Abstract available


  5. DONIDA BM, Tomasello G, Ghidini M, Buffoli F, et al
    Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy.
    BMC Cancer. 2019;19:212.
    PubMed     Text format     Abstract available


  6. LEE CM, Park JH, In Choi C, Lee HH, et al
    A multi-center prospective randomized controlled trial (phase III) comparing the quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric Cancer (study protocol).
    BMC Cancer. 2019;19:206.
    PubMed     Text format     Abstract available


    February 2019
  7. LIAN L, Li XL, Xu MD, Li XM, et al
    VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer.
    BMC Cancer. 2019;19:183.
    PubMed     Text format     Abstract available


  8. MAO Y, Yang W, Qi Q, Yu F, et al
    Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review.
    BMC Cancer. 2019;19:164.
    PubMed     Text format     Abstract available


  9. KIM TM, Ko YH, Ha SJ, Lee HH, et al
    Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
    BMC Cancer. 2019;19:119.
    PubMed     Text format     Abstract available


    January 2019
  10. LI Z, Wang Y, Ying X, Shan F, et al
    Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis.
    BMC Cancer. 2019;19:80.
    PubMed     Text format     Abstract available


  11. BUSTOS-CARPINTEYRO AR, Oliveira C, Sousa A, Oliveira P, et al
    CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    BMC Cancer. 2019;19:69.
    PubMed     Text format     Abstract available


  12. BRAGA LLBC, Batista MHR, de Azevedo OGR, da Silva Costa KC, et al
    oipA "on" status of Helicobacter pylori is associated with gastric cancer in North-Eastern Brazil.
    BMC Cancer. 2019;19:48.
    PubMed     Text format     Abstract available


  13. ZHANG X, Shen B, Cui Y
    Ago HITS-CLIP expands microRNA-mRNA interactions in nucleus and cytoplasm of gastric cancer cells.
    BMC Cancer. 2019;19:29.
    PubMed     Text format     Abstract available


  14. LIN MQ, Wang JB, Zheng CH, Li P, et al
    A modified subclassification to evaluate the survival of patients with N3 gastric cancer: an international database study.
    BMC Cancer. 2019;19:21.
    PubMed     Text format     Abstract available


  15. SHI Y, Huang X, Chen G, Wang Y, et al
    miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner.
    BMC Cancer. 2019;19:14.
    PubMed     Text format     Abstract available


    December 2018
  16. ZHANG J, Qiu W, Liu H, Qian C, et al
    Genomic alterations in gastric cancers discovered via whole-exome sequencing.
    BMC Cancer. 2018;18:1270.
    PubMed     Text format     Abstract available


  17. MORI M, Shuto K, Kosugi C, Narushima K, et al
    An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer.
    BMC Cancer. 2018;18:1261.
    PubMed     Text format     Abstract available


    November 2018
  18. LI Z, Shan F, Ying X, Xue K, et al
    Laparoscopic versus open gastrectomy for elderly local advanced gastric cancer patients: study protocol of a phase II randomized controlled trial.
    BMC Cancer. 2018;18:1118.
    PubMed     Text format     Abstract available


  19. BEOM SH, Choi YY, Baek SE, Li SX, et al
    Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy.
    BMC Cancer. 2018;18:1116.
    PubMed     Text format     Abstract available


  20. LIU J, Huang C, Peng C, Xu F, et al
    Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ beta-catenin pathway.
    BMC Cancer. 2018;18:1099.
    PubMed     Text format     Abstract available


  21. HUANG ZN, Chen QY, Zheng CH, Li P, et al
    Are the indications for postoperative radiotherapy in the NCCN guidelines for patients with gastric adenocarcinoma too broad? A study based on the SEER database.
    BMC Cancer. 2018;18:1064.
    PubMed     Text format     Abstract available


    October 2018
  22. MAGALHAES L, Quintana LG, Lopes DCF, Vidal AF, et al
    APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes.
    BMC Cancer. 2018;18:1055.
    PubMed     Text format     Abstract available


  23. LIU X, Cai H, Sheng W, Huang H, et al
    microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer.
    BMC Cancer. 2018;18:1048.
    PubMed     Text format     Abstract available


  24. XIE JW, Lu J, Wang JB, Lin JX, et al
    Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
    BMC Cancer. 2018;18:1021.
    PubMed     Text format     Abstract available


  25. YAPRAK G, Gemici C, Temizkan S, Ozdemir S, et al
    Osteoporosis development and vertebral fractures after abdominal irradiation in patients with gastric cancer.
    BMC Cancer. 2018;18:972.
    PubMed     Text format     Abstract available


  26. HE H, Li H, Su X, Li Z, et al
    Study on safety of laparoscopic total gastrectomy for clinical stage I gastric cancer: the protocol of the CLASS02-01 multicenter randomized controlled clinical trial.
    BMC Cancer. 2018;18:944.
    PubMed     Text format     Abstract available


    September 2018
  27. CHEN M, Jiang B, He B, Tang M, et al
    Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer.
    BMC Cancer. 2018;18:923.
    PubMed     Text format     Abstract available


  28. SLAGTER AE, Jansen EPM, van Laarhoven HWM, van Sandick JW, et al
    CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in res
    BMC Cancer. 2018;18:877.
    PubMed     Text format     Abstract available


  29. FENG F, Liu J, Wang F, Zheng G, et al
    Prognostic value of differentiation status in gastric cancer.
    BMC Cancer. 2018;18:865.
    PubMed     Text format     Abstract available


    August 2018
  30. LIU W, Fan Y, Shi Y, Lin Z, et al
    Knockdown of TIPE2 increases the proliferation in lipopolysaccharide-stimulated gastric cancer cells.
    BMC Cancer. 2018;18:857.
    PubMed     Text format     Abstract available


  31. HUSSEIN UK, Park HS, Bae JS, Kim KM, et al
    Expression of oxidized protein tyrosine phosphatase and gammaH2AX predicts poor survival of gastric carcinoma patients.
    BMC Cancer. 2018;18:836.
    PubMed     Text format     Abstract available


  32. LI N, Wang X, Tang Y, Zhao D, et al
    A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer.
    BMC Cancer. 2018;18:803.
    PubMed     Text format     Abstract available


  33. HU D, Peng F, Lin X, Chen G, et al
    Prediction of three lipid derivatives for postoperative gastric cancer mortality: the Fujian prospective investigation of cancer (FIESTA) study.
    BMC Cancer. 2018;18:785.
    PubMed     Text format     Abstract available


    July 2018
  34. HWANG H, Lee KM, Son KL, Jung D, et al
    Incidence and risk factors of subsyndromal delirium after curative resection of gastric cancer.
    BMC Cancer. 2018;18:765.
    PubMed     Text format     Abstract available


  35. WANG Z, Li M, Xu Z, Jiang Y, et al
    Improvements to the gastric cancer tumor-node-metastasis staging system based on computer-aided unsupervised clustering.
    BMC Cancer. 2018;18:706.
    PubMed     Text format     Abstract available


    June 2018
  36. LIU X, Zhang D, Lin E, Chen Y, et al
    Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer.
    BMC Cancer. 2018;18:699.
    PubMed     Text format     Abstract available


  37. WANG Y, Cheng X, Cui YH, Hou J, et al
    Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis.
    BMC Cancer. 2018;18:702.
    PubMed     Text format     Abstract available


  38. WANG Y, Chen Y, Li X, Hu W, et al
    Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm.
    BMC Cancer. 2018;18:691.
    PubMed     Text format     Abstract available


  39. ZHAO G, Jiang T, Liu Y, Huai G, et al
    Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
    BMC Cancer. 2018;18:676.
    PubMed     Text format     Abstract available


  40. LIU X, Ma M, Huang H, Wang Y, et al
    Effect of perioperative blood transfusion on prognosis of patients with gastric cancer: a retrospective analysis of a single center database.
    BMC Cancer. 2018;18:649.
    PubMed     Text format     Abstract available


  41. KUBO N, Yoshizawa J, Hanaoka T
    Solitary metastasis to a superior mediastinal lymph node after distal gastrectomy for gastric cancer: a case report.
    BMC Cancer. 2018;18:627.
    PubMed     Text format     Abstract available


    May 2018
  42. LIU Z, Zheng G, Liu J, Liu S, et al
    Clinicopathological features, surgical strategy and prognosis of duodenal gastrointestinal stromal tumors: a series of 300 patients.
    BMC Cancer. 2018;18:563.
    PubMed     Text format     Abstract available


  43. WANG G, Zhao J, Song Y, Zhang W, et al
    Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer.
    BMC Cancer. 2018;18:547.
    PubMed     Text format     Abstract available


  44. SCHNEIDER PM, Eshmuminov D, Rordorf T, Vetter D, et al
    (18)FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study.
    BMC Cancer. 2018;18:548.
    PubMed     Text format     Abstract available


  45. HSIEH YY, Tung SY, Pan HY, Yen CW, et al
    Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients.
    BMC Cancer. 2018;18:508.
    PubMed     Text format     Abstract available


  46. HUANG Z, Liu Y, Yang C, Li X, et al
    Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
    BMC Cancer. 2018;18:515.
    PubMed     Text format     Abstract available


  47. HONG SA, Yoo SH, Lee HH, Sun S, et al
    Prognostic value of Dickkopf-1 and ss-catenin expression in advanced gastric cancer.
    BMC Cancer. 2018;18:506.
    PubMed     Text format     Abstract available


  48. KHAN S, Zhu LP, Zhang Y, Chen X, et al
    Laterally spreading tumour of the distal stomach: a case report.
    BMC Cancer. 2018;18:502.
    PubMed     Text format     Abstract available


    April 2018
  49. WANG T, Lu ZY, Tu XF, Zhang SH, et al
    Computerized tomography findings in calcified signet-ring gastric cancer receiving chemotherapy: a case report.
    BMC Cancer. 2018;18:474.
    PubMed     Text format     Abstract available


  50. LINK H, Angele M, Schuller M, Ganschow P, et al
    Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer.
    BMC Cancer. 2018;18:483.
    PubMed     Text format     Abstract available


  51. ZHANG C, Li Z, Xu L, Che X, et al
    CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
    BMC Cancer. 2018;18:462.
    PubMed     Text format     Abstract available


  52. ITO S, Ohashi Y, Sasako M
    Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial.
    BMC Cancer. 2018;18:449.
    PubMed     Text format     Abstract available


  53. BRENKMAN HJF, Gertsen EC, Vegt E, van Hillegersberg R, et al
    Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study).
    BMC Cancer. 2018;18:450.
    PubMed     Text format     Abstract available


  54. SUN XJ, Shi JF, Guo LW, Huang HY, et al
    Medical expenses of urban Chinese patients with stomach cancer during 2002-2011: a hospital-based multicenter retrospective study.
    BMC Cancer. 2018;18:435.
    PubMed     Text format     Abstract available


  55. LIU HN, Wu H, Tseng YJ, Chen YJ, et al
    Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer.
    BMC Cancer. 2018;18:415.
    PubMed     Text format     Abstract available


  56. GIRARDI DM, de Lima MA, Pereira GCB, Negrao MV, et al
    Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis.
    BMC Cancer. 2018;18:378.
    PubMed     Text format     Abstract available


    March 2018
  57. SUNDAR R, Rha SY, Yamaue H, Katsuda M, et al
    A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer.
    BMC Cancer. 2018;18:332.
    PubMed     Text format     Abstract available


  58. ZHANG N, Chai D, Du H, Li K, et al
    Expression of Reg IV and SOX9 and their correlation in human gastric cancer.
    BMC Cancer. 2018;18:344.
    PubMed     Text format     Abstract available


  59. HAMASHIMA C, Sano H
    Association between age factors and strategies for promoting participation in gastric and colorectal cancer screenings.
    BMC Cancer. 2018;18:345.
    PubMed     Text format     Abstract available


  60. MULLER V, Clemens M, Jassem J, Al-Sakaff N, et al
    Long-term trastuzumab (Herceptin(R)) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer.
    BMC Cancer. 2018;18:295.
    PubMed     Text format     Abstract available


  61. HIRAHARA N, Tajima Y, Fujii Y, Kaji S, et al
    Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis.
    BMC Cancer. 2018;18:285.
    PubMed     Text format     Abstract available


    February 2018
  62. LEE YH, Lee JW, Jang HS
    Correction to: Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer.
    BMC Cancer. 2018;18:232.
    PubMed     Text format     Abstract available


  63. JIAO XD, Ding C, Zang YS, Yu G, et al
    Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report.
    BMC Cancer. 2018;18:206.
    PubMed     Text format     Abstract available


  64. NAMIKAWA T, Maeda H, Kitagawa H, Oba K, et al
    Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol.
    BMC Cancer. 2018;18:186.
    PubMed     Text format     Abstract available


  65. AHN MJ, Lee K, Lee KH, Kim JW, et al
    Combination of anti-PD-1 therapy and stereotactic radiosurgery for a gastric cancer patient with brain metastasis: a case report.
    BMC Cancer. 2018;18:173.
    PubMed     Text format     Abstract available


  66. FENG F, Zheng G, Guo X, Liu Z, et al
    Impact of body mass index on surgical outcomes of gastric cancer.
    BMC Cancer. 2018;18:151.
    PubMed     Text format     Abstract available


  67. KIM SH, Yoo HS, Joo MK, Kim T, et al
    Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells.
    BMC Cancer. 2018;18:150.
    PubMed     Text format     Abstract available


  68. MARIETTE C, Renaud F, Piessen G, Gele P, et al
    The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers.
    BMC Cancer. 2018;18:139.
    PubMed     Text format     Abstract available


  69. BRAGA-NETO MB, Carneiro JG, de Castro Barbosa AM, Silva IS, et al
    Clinical characteristics of distal gastric cancer in young adults from Northeastern Brazil.
    BMC Cancer. 2018;18:131.
    PubMed     Text format     Abstract available


    January 2018
  70. MIAO ZF, Liu XY, Wang ZN, Zhao TT, et al
    Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis.
    BMC Cancer. 2018;18:118.
    PubMed     Text format     Abstract available


  71. MATSUMOTO H, Kawazoe A, Shimada K, Fukuoka S, et al
    A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.
    BMC Cancer. 2018;18:120.
    PubMed     Text format     Abstract available


  72. NISHIBEPPU K, Komatsu S, Ichikawa D, Imamura T, et al
    Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
    BMC Cancer. 2018;18:108.
    PubMed     Text format     Abstract available


  73. CAO QH, Liu F, Li CZ, Liu N, et al
    Testes-specific protease 50 (TSP50) promotes invasion and metastasis by inducing EMT in gastric cancer.
    BMC Cancer. 2018;18:94.
    PubMed     Text format     Abstract available


  74. MACALINDONG SS, Kim KH, Nam BH, Ryu KW, et al
    Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center.
    BMC Cancer. 2018;18:73.
    PubMed     Text format     Abstract available


  75. LI Z, Li Z, Zhang L, Liu Q, et al
    Staging laparoscopy for locally advanced gastric cancer in Chinese patients: a multicenter prospective registry study.
    BMC Cancer. 2018;18:63.
    PubMed     Text format     Abstract available


  76. SAEKI H, Emi Y, Oki E, Tokunaga S, et al
    Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy.
    BMC Cancer. 2018;18:57.
    PubMed     Text format     Abstract available


  77. ZENG B, Shi W, Tan G
    MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
    BMC Cancer. 2018;18:34.
    PubMed     Text format     Abstract available


    December 2017
  78. HUANG J, He Y, Mcleod HL, Xie Y, et al
    miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ beta-catenin/EMT signaling cascade in gastric cancer.
    BMC Cancer. 2017;17:886.
    PubMed     Text format     Abstract available


  79. LU Y, Xu Q, Zuo Y, Liu L, et al
    Isoprenaline/beta2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.
    BMC Cancer. 2017;17:875.
    PubMed     Text format     Abstract available


  80. KELLER S, Kneissl J, Grabher-Meier V, Heindl S, et al
    Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis.
    BMC Cancer. 2017;17:845.
    PubMed     Text format     Abstract available


  81. CAO GD, Chen K, Chen B, Xiong MM, et al
    Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.
    BMC Cancer. 2017;17:841.
    PubMed     Text format     Abstract available


  82. KAWAMOTO Y, Komatsu Y, Yuki S, Sawada K, et al
    Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.
    BMC Cancer. 2017;17:837.
    PubMed     Text format     Abstract available


    November 2017
  83. GHOSH S, Bankura B, Ghosh S, Saha ML, et al
    Polymorphisms in ADH1B and ALDH2 genes associated with the increased risk of gastric cancer in West Bengal, India.
    BMC Cancer. 2017;17:782.
    PubMed     Text format     Abstract available


  84. RYU BK, Lee MG, Kim NH, Lee KY, et al
    Bidirectional alteration of Cav-1 expression is associated with mitogenic conversion of its function in gastric tumor progression.
    BMC Cancer. 2017;17:766.
    PubMed     Text format     Abstract available


  85. HAMASHIMA C, Narisawa R, Ogoshi K, Kato T, et al
    Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers.
    BMC Cancer. 2017;17:740.
    PubMed     Text format     Abstract available


  86. FENG F, Tian Y, Xu G, Liu Z, et al
    Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    BMC Cancer. 2017;17:737.
    PubMed     Text format     Abstract available


    October 2017
  87. GUAN P, Chen Z, Zhang L, Pan L, et al
    Dilemmas in a pregnant woman with myelofibrosis secondary to signet ring adenocarcinoma: a case report.
    BMC Cancer. 2017;17:679.
    PubMed     Text format     Abstract available


  88. LEE HH, Lee SH, Song KY, Na SJ, et al
    Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.
    BMC Cancer. 2017;17:670.
    PubMed     Text format     Abstract available


  89. SANCHEZ-ZAUCO N, Torres J, Gomez A, Camorlinga-Ponce M, et al
    Correction to: Circulating blood levels of IL-6, IFN-gamma, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    BMC Cancer. 2017;17:669.
    PubMed     Text format    


  90. LIU S, Zhang Y, Chen L, Guan W, et al
    Whole-lesion apparent diffusion coefficient histogram analysis: significance in T and N staging of gastric cancers.
    BMC Cancer. 2017;17:665.
    PubMed     Text format     Abstract available


    September 2017
  91. REYNOLDS KL, Bedard PL, Lee SH, Lin CC, et al
    A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
    BMC Cancer. 2017;17:646.
    PubMed     Text format     Abstract available


  92. YE J, Huang J, Xu J, Huang Q, et al
    ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    BMC Cancer. 2017;17:626.
    PubMed     Text format     Abstract available


    August 2017
  93. PARK SM, Lee J, Kim YA, Chang YJ, et al
    Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea.
    BMC Cancer. 2017;17:600.
    PubMed     Text format     Abstract available


  94. JI X, Bu ZD, Li ZY, Wu AW, et al
    Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients.
    BMC Cancer. 2017;17:558.
    PubMed     Text format     Abstract available


  95. LEE YH, Lee JW, Jang HS
    Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer.
    BMC Cancer. 2017;17:541.
    PubMed     Text format     Abstract available


    July 2017
  96. HAAG GM, Stocker G, Quidde J, Jaeger D, et al
    Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.
    BMC Cancer. 2017;17:509.
    PubMed     Text format     Abstract available


    June 2017
  97. YOSHIZAWA J, Kubo N, Ishizone S, Karasawa F, et al
    Curative resection by splenectomy for solitary splenic metastasis from early gastric cancer: a case report and literature review.
    BMC Cancer. 2017;17:436.
    PubMed     Text format     Abstract available


    May 2017
  98. SANCHEZ-ZAUCO N, Torres J, Gomez A, Camorlinga-Ponce M, et al
    Circulating blood levels of IL-6, IFN-gamma, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    BMC Cancer. 2017;17:384.
    PubMed     Text format     Abstract available


  99. CHANG YW, Oh CH, Kim JW, Lee JW, et al
    Combination of Helicobacter pylori infection and the interleukin 8 -251 T > A polymorphism, but not the mannose-binding lectin 2 codon 54 G > A polymorphism, might be a risk factor of gastric cancer.
    BMC Cancer. 2017;17:388.
    PubMed     Text format     Abstract available


  100. YOSHIZAWA J, Ishizone S, Ikeyama M, Nakayama J, et al
    Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
    BMC Cancer. 2017;17:368.
    PubMed     Text format     Abstract available


  101. JI X, Yan Y, Bu ZD, Li ZY, et al
    The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival.
    BMC Cancer. 2017;17:345.
    PubMed     Text format     Abstract available


    April 2017
  102. SAITO H, Fushida S, Miyashita T, Oyama K, et al
    Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study.
    BMC Cancer. 2017;17:294.
    PubMed     Text format     Abstract available


  103. SHIN HB, An JY, Lee SH, Choi YY, et al
    Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
    BMC Cancer. 2017;17:287.
    PubMed     Text format     Abstract available


  104. KIM GM, Kim SJ, Song SK, Kim HR, et al
    Prevalence and prognostic implications of psychological distress in patients with gastric cancer.
    BMC Cancer. 2017;17:283.
    PubMed     Text format     Abstract available


  105. WU Z, Zhao J, Gao P, Song Y, et al
    Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis.
    BMC Cancer. 2017;17:275.
    PubMed     Text format     Abstract available


  106. XING X, Cai W, Ma S, Wang Y, et al
    Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer.
    BMC Cancer. 2017;17:268.
    PubMed     Text format     Abstract available


    March 2017
  107. SHU P, Qin J, Shen K, Chen W, et al
    The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III.
    BMC Cancer. 2017;17:238.
    PubMed     Text format     Abstract available


  108. WANG H, Lu J, Tang J, Chen S, et al
    Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.
    BMC Cancer. 2017;17:191.
    PubMed     Text format     Abstract available


  109. LIU X, Guo W, Zhang W, Yin J, et al
    A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.
    BMC Cancer. 2017;17:188.
    PubMed     Text format     Abstract available


  110. LEE JW, Choi MH, Lee YJ, Ali B, et al
    Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection.
    BMC Cancer. 2017;17:185.
    PubMed     Text format     Abstract available


  111. HAMASHIMA C, Sasazuki S, Inoue M, Tsugane S, et al
    Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
    BMC Cancer. 2017;17:183.
    PubMed     Text format     Abstract available


    February 2017
  112. LUO Y, Chen J, Huang K, Lin Y, et al
    Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
    BMC Cancer. 2017;17:154.
    PubMed     Text format     Abstract available


  113. CHEN Z, Liang W
    Myopericytoma occurrence in the liver and stomach space: imaging performance.
    BMC Cancer. 2017;17:143.
    PubMed     Text format     Abstract available


  114. KOMAKI K, Kusaba T, Tanaka M, Kado H, et al
    Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study.
    BMC Cancer. 2017;17:144.
    PubMed     Text format     Abstract available


  115. LOZANO-POPE I, Sharma A, Matthias M, Doran KS, et al
    Effect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancer.
    BMC Cancer. 2017;17:133.
    PubMed     Text format     Abstract available


  116. YU B, Chen X, Li J, Gu Q, et al
    microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer.
    BMC Cancer. 2017;17:109.
    PubMed     Text format     Abstract available


    January 2017
  117. HUR H, Ham IH, Lee D, Jin H, et al
    Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.
    BMC Cancer. 2017;17:87.
    PubMed     Text format     Abstract available


  118. RAO SV, Solum G, Niederdorfer B, Norsett KG, et al
    Gastrin activates autophagy and increases migration and survival of gastric adenocarcinoma cells.
    BMC Cancer. 2017;17:68.
    PubMed     Text format     Abstract available


  119. DIAO D, Cheng Y, Song Y, Zhang H, et al
    D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer.
    BMC Cancer. 2017;17:56.
    PubMed     Text format     Abstract available


  120. LEE NK, Lee JH, Ivan C, Ling H, et al
    MALAT1 promoted invasiveness of gastric adenocarcinoma.
    BMC Cancer. 2017;17:46.
    PubMed     Text format     Abstract available


  121. OKAZAKI M, Fushida S, Harada S, Tsukada T, et al
    Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.
    BMC Cancer. 2017;17:23.
    PubMed     Text format     Abstract available


  122. SONG H, Fang F, Valdimarsdottir U, Lu D, et al
    Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.
    BMC Cancer. 2017;17:2.
    PubMed     Text format     Abstract available


    December 2016
  123. PU WY, Zhang R, Xiao L, Wu YY, et al
    Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA.
    BMC Cancer. 2016;16:943.
    PubMed     Text format     Abstract available


  124. HOFHEINZ R, Clouth J, Borchardt-Wagner J, Wagner U, et al
    Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.
    BMC Cancer. 2016;16:937.
    PubMed     Text format     Abstract available


    November 2016
  125. SEO SH, Kim SE, Kang YK, Ryoo BY, et al
    Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients.
    BMC Cancer. 2016;16:900.
    PubMed     Text format     Abstract available


    October 2016
  126. FENG M, Yao G, Yu H, Qing Y, et al
    Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer.
    BMC Cancer. 2016;16:794.
    PubMed     Text format     Abstract available


  127. JI X, Fu T, Bu ZD, Zhang J, et al
    Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer.
    BMC Cancer. 2016;16:765.
    PubMed     Text format     Abstract available


    January 2016
  128. KUPCINSKAITE-NOREIKIENE R, Ugenskiene R, Noreika A, Rudzianskas V, et al
    Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach.
    BMC Cancer. 2016;16:40.
    PubMed     Text format     Abstract available


  129. ZOU K, Yang S, Zheng L, Yang C, et al
    Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system review.
    BMC Cancer. 2016;16:737.
    PubMed     Text format     Abstract available


  130. PARK WC, Kim HR, Kang DB, Ryu JS, et al
    Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer.
    BMC Cancer. 2016;16:358.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: